Medical & Technical Translation Quality Framework

## ROLE

You are a senior medical and technical translation quality manager with 15+ years of experience in regulated industries including pharmaceuticals, medical devices, clinical research, biotechnology, and healthcare IT. You hold relevant qualifications in both translation and the subject domain, and you have managed translation quality programs compliant with ISO 17100 (Translation Services), ISO 13485 (Medical Devices QMS), EU MDR/IVDR, FDA 21 CFR Part 11, and ICH GCP guidelines. You understand that medical and technical translation errors can endanger patient safety, delay regulatory approvals, trigger product recalls, and expose organizations to legal liability — and you design quality systems that prevent these outcomes.

## OBJECTIVE

Develop a comprehensive translation quality framework for [ORGANIZATION TYPE: pharmaceutical company / medical device manufacturer / CRO / hospital system / biotech firm / regulatory consultancy] translating [DOCUMENT TYPES: clinical trial protocols / patient information leaflets / IFUs (Instructions for Use) / regulatory submissions / medical device labeling / pharmacovigilance reports / informed consent forms / clinical study reports / SOPs / medical journal articles / CME materials] from [SOURCE LANGUAGE] into [TARGET LANGUAGE(S): list all]. The framework must comply with [REGULATORY REQUIREMENTS: EU MDR / FDA / ICH / ISO 17100 / ISO 13485 / GxP / other] and support [ANNUAL VOLUME: e.g., 2 million words across 15 languages].

## TASK: MEDICAL & TECHNICAL TRANSLATION QUALITY FRAMEWORK

### Regulatory Compliance Foundation
Map the regulatory requirements that govern translated content for each document type and target market. For EU markets, the Medical Device Regulation (EU MDR 2017/745) requires that Instructions for Use and labeling be provided in the official language(s) of each Member State where the device is placed on the market. The language must be [REQUIREMENT: clearly understandable to the intended user — layperson for patient-facing, professional for HCP-facing]. Document the specific language requirements per EU Member State, noting countries with multiple official languages (Belgium, Switzerland, Finland) and any national deviations from EU requirements.

For FDA-regulated content, document the English-language requirements for US submissions and the translation requirements for products marketed in non-English-speaking territories. For clinical trial documentation, map the ICH E6 GCP requirements for informed consent in the local language and the sponsor's obligations to ensure translation quality. For each regulatory requirement, link it to a specific quality control step in this framework, creating a traceability matrix that auditors can review to verify compliance.

Establish translator qualification requirements that meet regulatory expectations. Translators working on medical and technical content must demonstrate: native-level proficiency in the target language, subject matter expertise in [DOMAIN: clinical, regulatory, medical devices, pharmaceuticals] verified through [METHOD: testing / portfolio review / certification / academic credentials], familiarity with the regulatory environment of the target market, and experience with the specific document types being translated. Maintain a qualified translator database with current CVs, qualification records, annual competency assessments, and confidentiality agreements. Reviewers must have equivalent or higher qualifications and may additionally require [CREDENTIALS: medical degree / pharmacy degree / clinical research certification / regulatory affairs certification] depending on the document type.

### Translation Process Controls
Define a controlled translation process aligned with ISO 17100 and GxP principles. Every translation project must follow a documented procedure with records at each step. Step 1: Project intake — verify source document completeness, identify the document type and regulatory classification, assign the appropriate quality level (safety-critical content receives the highest level), and select qualified translators and reviewers from the approved database.

Step 2: Terminology management. Before translation begins, verify and update the project terminology database against [REFERENCES: MedDRA (Medical Dictionary for Regulatory Activities) in target language / WHO-INN (International Nonproprietary Names) / ICD coding terminology / SNOMED CT / device-specific terminology from the manufacturer's approved glossary / pharmacopeial terminology]. For clinical trial content, ensure that endpoint terminology, efficacy and safety terms, and statistical methodology terms are translated consistently with previously submitted documents in the same program — inconsistency across submissions can trigger regulatory queries.

Step 3: Translation with concurrent reference verification. Translators must verify factual content against authoritative sources as they translate. Drug dosages, contraindications, warnings, measurement units, anatomical terminology, and procedural instructions must be cross-checked — a translation error that changes "10 mg" to "100 mg" or "left" to "right" in a surgical instruction can have fatal consequences. All numerical content, units of measurement, and directional/positional instructions receive mandatory double-verification.

Step 4: Revision by a second qualified linguist (as required by ISO 17100). The reviser compares the translation against the source text with access to the terminology database, reference materials, and any translator notes. The reviser evaluates accuracy, completeness, terminological consistency, grammar and style, compliance with the target language's medical writing conventions, and adherence to any client-specific style guides. All reviser changes must be tracked and visible to the original translator for learning and dispute resolution.

### Quality Metrics & Error Classification
Implement a medical translation-specific error classification system. Adapt the MQM (Multidimensional Quality Metrics) framework with medical severity weighting:

**Critical Errors (immediate patient safety risk):** Mistranslation of dosage, contraindication, warning, or safety instruction. Omission of safety-relevant information. Incorrect translation of anatomical terms, drug names, or medical procedures. Numerical errors in clinical data. Any error that could lead to patient harm if the translated document is followed. Critical error threshold: ZERO tolerance — any critical error requires full re-review of the entire document.

**Major Errors (regulatory or clinical significance):** Terminological inconsistency that could cause confusion. Mistranslation that changes clinical meaning but does not directly endanger safety. Grammatical errors that create ambiguity in instructions. Missing or incorrect regulatory standard references. Major error threshold: [LIMIT: fewer than 3 per 1000 words].

**Minor Errors (quality and professionalism):** Stylistic preferences, minor grammatical issues that do not affect meaning, formatting inconsistencies, and typographical errors that do not involve medical content. Minor error threshold: [LIMIT: fewer than 5 per 1000 words].

Calculate a composite quality score using the formula: Quality Score = 100 - (Critical × [WEIGHT: 25] + Major × [WEIGHT: 5] + Minor × [WEIGHT: 1]) / (word count / 1000). Set minimum acceptable quality scores: [SCORE: 98+] for safety-critical documents (IFUs, labeling, patient information), [SCORE: 96+] for regulatory submissions, [SCORE: 94+] for internal technical documents. Track quality scores by translator, language pair, document type, and project over time to identify trends and target improvement efforts.

### Verification & Validation Protocols
Design document-type-specific verification protocols. For patient-facing documents (patient information leaflets, informed consent forms, patient-reported outcome measures), conduct a readability and comprehension assessment. After linguistic review, have [NUMBER: 2-3] representative target-audience readers review the translated document for clarity and understandability. For validated instruments (PRO measures, quality of life questionnaires), follow the established linguistic validation methodology: forward translation, back translation, cognitive debriefing, and harmonization — document each step for regulatory submission.

For medical device labeling and IFUs, perform a usability-focused review. A reviewer with the target user's profile (healthcare professional or patient, depending on device classification) reads the translated instructions and verifies that every step is clear, unambiguous, and actionable. Simulate the user experience: can the instructions be followed without confusion using only the translated document and the physical device? Flag any instruction that could be misinterpreted due to translation choices.

For regulatory submission documents (clinical study reports, CTD modules, MAA/NDA documentation), perform a regulatory consistency check. Cross-reference the translation against previously submitted documents in the same regulatory program to ensure terminological consistency, consistent data presentation, and alignment with the regulatory authority's preferred terminology in [TARGET LANGUAGE]. Review all tables, figures, and data listings to verify that translated headers, footnotes, and annotations match the numerical data accurately.

### CAPA & Continuous Improvement
Establish a Corrective and Preventive Action (CAPA) system for translation quality issues. When errors are detected post-delivery, classify the error severity, conduct a root cause analysis (translator qualification gap, terminology gap, process failure, unclear source, reviewer oversight), implement immediate correction of the specific error, and develop preventive measures to eliminate the root cause. Track all CAPAs in a quality management system and review them during [FREQUENCY: quarterly] management reviews.

Build a continuous improvement program. Maintain a living lessons-learned database organized by language pair, document type, and error category. Update terminology databases and style guides after every project based on reviser feedback and CAPA findings. Conduct annual translator requalification assessments using blind quality evaluations of recent work. Benchmark translation quality against industry standards by participating in [PROGRAMS: GALA / EUATC / ATA quality benchmarking initiatives]. Report quality KPIs to senior management including: on-time delivery rate, quality score trends by language, CAPA closure rate, client satisfaction scores, and regulatory audit findings related to translation quality.